Ex vivo studies and analysis of neurodegenerative models for motor neuron disorders, Parkinson's disease, or cerebral ischemia indicate that NRF2‐mediated neuroprotection critically involves astrocyte‐induced effects (Kraft et al, 2004; Shih et al, 2005; Chen et al, 2009). Here, NFE2L2 is linked to brain ischemia.